5-substituted picolinic acid compounds and their production process
CA 2253080 C · Owner: Satake, Kunio · Inventors: Yoshikawa, Nobuji; Satake, Kunio; Kojima, Nakao
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides novel 5-substituted picolinic acid compounds of formula (I) or a pharmaceutically acceptable salt thereof: (see fig. I), wherein R1 and R2 are independently H C2-C6 acyl or halo-substituted benzoyl; and R3 is -C(O)O-C1-C6 alkyl, C(O)OH, CN, CONH2 CONHCH3, CON(CH3)2, 1-methyltetrazole or 2-methyltetrazole with the proviso that when R2 is acetyl and R3 is methoxycarbonyl, R1 is not H; and that when R3 is CN CONH2, CONHCH3, CON(CH3)2, 1-methyltetrazole or 2-methyltetrazole R1 and R2 are H. The present invention also relates to a pharmaceutical composition comprising compound of the present invention which is useful in the treatment of, IL-1 and TNF mediated …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 2, 1998 and granted July 2, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 2, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 2, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.